Streptococcal and Staphylococcal Infections
Streptococci and staphylococci are among the most common bacteria to cause human disease. They range from sore throats and skin infections to pneumonia, sepsis, toxic shock and serious heart and bone infections.
The Streptococcal and Staphylococcal Infections session at Infectious 2027 covers the clinical care and science of these infections. It links closely with mechanisms of bacterial pathogenesis, which explains how these bacteria cause disease.
These bacteria are common and often live harmlessly on the skin or in the throat. When they invade, they can cause serious infections such as sepsis, pneumonia and meningitis. Some strains are resistant to common antibiotics. Quick diagnosis and the right treatment are essential.
Key Topics in Streptococcal and Staphylococcal Infections
• MRSA and drug-resistant staphylococci
• Invasive group A streptococcal disease
• Pneumococcal disease and vaccines
• Group B streptococcus in newborns
• Skin and soft tissue infections
• Bloodstream infections and endocarditis
• Bone and joint infections
• Toxin-mediated disease
• Rheumatic fever and heart disease
• New treatments and decolonisation
Recent Advances in Streptococcal and Staphylococcal Infections
Several countries have reported rises in invasive group A streptococcal infections, prompting new research on causes and prevention. MRSA remains a major hospital and community threat, and stewardship from infectious diseases prevention, control and cure is key to slowing resistance.
Newer pneumococcal vaccines, covered in vaccine development and immunization, protect against more strains. Genomics from molecular biology and genomics is helping track resistant strains between hospitals.
Rapid tests are helping identify these bacteria and their resistance faster. New vaccines against more pneumococcal strains are being rolled out. Hospitals are tracking MRSA spread using genomic methods. Research is also exploring vaccines against group A streptococcus and staphylococci.
Who Should Attend the Streptococcal and Staphylococcal Infections Session
• Infectious disease physicians and microbiologists
• Infection prevention and control teams
• Paediatricians and cardiologists
• Surgeons and orthopaedic specialists
• PhD students and early-career researchers
• Antibiotic and vaccine researchers
Why Present Your Research in Streptococcal and Staphylococcal Infections
Presenting at Infectious 2027 puts your research in front of clinicians and scientists worldwide. You can connect with colleagues in pediatric infectious diseases management working on infections in children. These infections are seen in every hospital. Your findings can help teams worldwide improve prevention and care.
Frequently Asked Questions
Can I present MRSA research?
Yes. MRSA and drug-resistant staphylococci are key topics.
Does this session include pneumococcal disease?
Yes. Pneumococcal disease and vaccines fit this session.
When is Infectious 2027?
Infectious 2027 runs from 11 to 13 March 2027 at Village Hotel Changi, Singapore, and online.